MARSHALL CRESPIN: Open Payments
NPI 1497125009 · FISHERSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,733 in 135 payments from 32 companies in 2025. Trend: 2023 $1,810 · 2024 $2,265 · 2025 $2,733
Food & beverage: $2,733
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $760 |
| UCB, Inc. | 10 | $212 |
| Celgene Corporation | 23 | $202 |
| Lundbeck LLC | 11 | $183 |
| Eisai Inc. | 2 | $119 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| ANI Pharmaceuticals, Inc. | 3 | $81 |
| Lilly USA, LLC | 4 | $78 |
| ARGENX US, INC. | 3 | $71 |
| Merz Pharmaceuticals, LLC | 3 | $70 |
Products named: BOTOX, QULIPTA, ZEPOSIA, VYEPTI, Leqembi, UBRELVY, Rystiggo, Fintepla.
Industry payments across VA — which companies pay providers there.
